AstraZeneca subpoenaed on Seroquel
Pharma Compliance Alert, November 1, 2006
Alaska and California subpoenaed AstraZeneca last month for information related to the marketing of the antipsychotic Seroquel, the company disclosed October 26 with its third-quarter results.
In September the company received a subpoena from the California Attorney General's Office seeking information about the marketing and sale of Seroquel in California and its status on the state's formulary.
Also in September, AstraZeneca received a subpoena from the Alaska Attorney General's Office seeking information relating to the safety and efficacy of Seroquel, as well as marketing practices relating to the drug. AstraZeneca says it is in the initial stages of responding to these requests for information.
The company also said it has received an informal enquiry from the US Securities and Exchange Commission seeking information about payments made to doctors and government officials in relation to AstraZeneca's businesses in "certain countries outside the US." The company says it is cooperating with the SEC.
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- Case Management Monthly, June 2012
- Searched